HOME >> MEDICINE >> NEWS
UQ scientist honoured for developing the world's first cancer vaccine

s designed for the developing world," he said.

"It will be sold first in the developed world, and of course there is a significant benefit for women in countries with effective Pap smear programs, as abnormal smears will be much less likely after vaccination, but the real need is for the developing world and to have this vaccine used routinely in young women to prevent cervical cancer in countries where there are no Pap smear programs to reduce the risk."

He said both companies involved in the development of the vaccine had indicated that they would introduce a differential pricing structure so developing countries could get the vaccine at a cheaper price.

"But cheaper isn't cheap. This is a vaccine which is technically quite difficult to make," he said.

"It will rely on the good graces of the Gates Foundation, the World Bank and the World Health Organisation's Expanded Vaccine Initiative to make sure this vaccine is made available as cheaply as possible to all the countries in the developing world that want to use it."

Final-stage clinical trials of the vaccine showed it to be 100 percent effective at preventing infection with the types of human papilloma virus (HPV) that are included in the vaccine, which are together responsible for about 70 percent of cervical cancer.

The results of the Phase III trials were announced in October 2005 by international pharmaceutical company Merck & Co. which is developing the product.

"It's very rare, almost unheard of, to achieve a 100 percent efficacy rate in any treatment, so the results are truly wonderful," Professor Frazer said.

"It's the first time in the world that a vaccine designed to prevent cancer has been developed, and it has happened right here in Australia.

"It's very encouraging to see such great results coming out of Australian research, and developed in conjunction with Australian company CSL, and international pharmaceutical compa
'"/>

Contact: Chris Saxby
c.saxby@uq.edu.au
61-733-652-479
Research Australia
23-Jan-2006


Page: 1 2 3

Related medicine news :

1. NIH scientists target future pandemic strains of H5N1 avian influenza
2. To be or not to be a scientist
3. Barrow scientists make headlines for their research on fixational eye movements
4. UD scientists invent novel hydrogels for repairing, regenerating human tissue
5. UK scientists set their sights on cure for AMD
6. QBI scientist looks at why stroke causes vision problems
7. Fat protein cuts blood vessel inflammation, may help heart, Jefferson scientists find
8. Smart mice teach scientists about learning process, brain disorders
9. Why predicting the next influenza pandemic is difficult and how scientists can best prepare
10. Young Australian scientist honored at international meeting
11. Sex and prenatal hormone exposure affect cognitive performance, Yerkes scientists find

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:6/25/2016)... , ... June 25, 2016 , ... "With 30 hand-drawn ... specific project," said Christina Austin - CEO of Pixel Film Studios. , ProHand ... all within Final Cut Pro X . Simply select a ProHand generator and ...
(Date:6/25/2016)... ... June 25, 2016 , ... Conventional wisdom preaches the benefits of ... of the latter, setting the bar too high can result in disappointment, perhaps even ... progress toward their goal. , Research from PsychTests.com reveals that behind ...
(Date:6/24/2016)... ... 24, 2016 , ... The Pulmonary Hypertension Association (PHA) learned ... receive two significant new grants to support its work to advance research and ... by recognizing patients, medical professionals and scientists for their work in fighting pulmonary ...
(Date:6/24/2016)... ... 2016 , ... People across the U.S. are sharpening their pencils and honing ... contest in which patients and their families pay tribute to a genetic counselor by ... Society of Genetic Counselors (NSGC) Annual Education Conference (AEC) this September. , In ...
(Date:6/24/2016)... ... ... National recruitment firm Slone Partners is pleased to announce the ... as Vice President of North American Capital Sales at HTG Molecular . ... team in the commercialization of the HTG EdgeSeq system and associated reagents in North ...
Breaking Medicine News(10 mins):
(Date:6/24/2016)... , June 24, 2016 VolitionRx ... of Dr. Edward Futcher to the ... effective June 23, 2016.Dr. Futcher was also appointed ... Governance Committees.  As a non-executive member of the ... and strategic counsel to VolitionRx in connection with ...
(Date:6/23/2016)... June 23, 2016 Research and Markets ... Market - Forecast to 2022" report to their offering. ... method for the patients with kidney failure, it replaces the ... from the patient,s blood and thus the treatment helps to ... chloride in balance. Increasing number of ESRD ...
(Date:6/23/2016)... 2016  In a startling report released today, National Safety ... lacking a comprehensive, proven plan to eliminate prescription opioid overdoses. ... how states are tackling the worst drug crisis in recorded U.S. ... Kentucky , New Mexico , ... Of the 28 failing states, three – Michigan ...
Breaking Medicine Technology:
Cached News: